Latest Period
Q4 2025
Security Snapshot
Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO) Institutional Ownership
CUSIP: 38000Q201
13F Institutional Holders and Ownership History for Q4 2025
Institutions Reporting
2
Shares (Excl. Options)
374,496
Price
$11.86
- Type / Class
- Equity / Ordinary Shares, par value $0.001 per share
- Symbol
- CBIO on Nasdaq
- Shares outstanding
- 13,839,146
- Price per share
- $11.86
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 374,496
- Total reported value
- $4,441,098
- % of total 13F portfolios
- 0%
- Share change
- +13,246
- Value change
- +$157,098
- Number of holders
- 2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CBIO - Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share is tracked under CUSIP 38000Q201.
- 2 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Latest quarter on this page is Q4 2025.
- Additional quarter-over-quarter change detail appears as history expands.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 38000Q201?
CUSIP 38000Q201 identifies CBIO - Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 38000Q201:
Significant Owners of Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| 1Globe Capital LLC | 10% | +64% | $20,839,816 | +$7,729,886 | 1,425,432 | +59% | 1Globe Capital LLC | 07 Oct 2025 |
| FMR LLC | 10% | 1,414,190 | FMR LLC | 30 Jun 2025 | ||||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | 1,391,196 | Venrock Healthcare Capital Partners III, L.P. | 13 Jun 2025 | ||||
| Adage Capital Management, L.P. | 0.37% | 50,912 | Adage Capital Management, L.P. | 20 Jun 2025 |
As of 31 Dec 2025, 2 institutional investors reported holding 374,496 shares of Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO). This represents 2.7% of the company’s total 13,839,146 outstanding shares.
Institutional Holders of Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 374,496 | $4,441,098 | +$157,098 | $11.86 | 2 |